Anxiolytic Market: Is "Personalized Psychiatry" Finally Replacing Trial-and-Error?
The global landscape for anxiety treatment is undergoing a radical shift as the market reaches an estimated value of $15.8 billion. For decades, patients often cycled through multiple medications before finding relief, but 2026 marks the rise of biomarker-guided therapy and genetic profiling. Pharmaceutical developers are increasingly leveraging these tools to tailor treatment regimens,...
0 Commentaires
0 Parts
449 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt